Related references
Note: Only part of the references are listed.Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders
Adrian Newman-Tancredi et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Brain5-HT1AReceptor Binding in Multiple System Atrophy: An [18F]-MPPF PETStudy
Marie Meyer et al.
MOVEMENT DISORDERS (2021)
Towards in vivo imaging of functionally active 5-HT1A receptors in schizophrenia: concepts and challenges
Oriane Razakarivony et al.
TRANSLATIONAL PSYCHIATRY (2021)
Validation of kinetic modeling of [15O]H2O PET using an image derived input function on hybrid PET/MRI
Mark B. Vestergaard et al.
NEUROIMAGE (2021)
[18F]F13640, a 5-HT1A Receptor Radiopharmaceutical Sensitive to Brain Serotonin Fluctuations
Matthieu Colom et al.
FRONTIERS IN NEUROSCIENCE (2021)
A positron emission tomography occupancy study of brexpiprazole at dopamine D-2 and D-3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
Ragy R. Girgis et al.
NEUROPSYCHOPHARMACOLOGY (2020)
The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets
Ria Fisher et al.
NEUROPHARMACOLOGY (2020)
The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques
R. Depoortere et al.
PARKINSONISM & RELATED DISORDERS (2020)
NLX-112, a highly selective 5-HT1A receptor agonist, mediates analgesia and antidepressant-like activity in rats via spinal cord and prefrontal cortex 5-HT1A receptors, respectively
A. Newman-Tancredi et al.
BRAIN RESEARCH (2018)
18F-F13640 preclinical evaluation in rodent, cat and primate as a 5-HT1A receptor agonist for PET neuroimaging
Benjamin Vidal et al.
BRAIN STRUCTURE & FUNCTION (2018)
Development of a Dedicated Rebinner with Rigid Motion Correction for the mMR PET/MR Scanner, and Validation in a Large Cohort of 11C-PIB Scans
Anthonin Reilhac et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Macroanatomy and 3D probabilistic atlas of the human insula
Isabelle Faillenot et al.
NEUROIMAGE (2017)
Multi-atlas attenuation correction supports full quantification of static and dynamic brain PET data in PET-MR
Ines Merida et al.
PHYSICS IN MEDICINE AND BIOLOGY (2017)
Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals
Benjamin Vidal et al.
NEUROPHARMACOLOGY (2016)
NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat
H. Iderberg et al.
EXPERIMENTAL NEUROLOGY (2015)
11C-CUMI-101, a PET Radioligand, Behaves as a Serotonin 1A Receptor Antagonist and Also Binds to α1 Adrenoceptors in Brain
Stal Saurav Shrestha et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Switching brain serotonin with oxytocin
Raphaelle Mottolese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Pinpointing brainstenn mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists
Ana P. Abdala et al.
FRONTIERS IN PHYSIOLOGY (2014)
PET Radiotracers for Molecular Imaging of Serotonin 5-HT1A Receptors
T. Billard et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study
S. Selvaraj et al.
MOLECULAR PSYCHIATRY (2012)
Effects of unilateral 6-OHDA lesions on [3H]-N-propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat
Mikael Palner et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue
Nicola Hendry et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Striatal and Extrastriatal Dopamine D2/D3 Receptors in Schizophrenia Evaluated With [18F]fallypride Positron Emission Tomography
Lawrence S. Kegeles et al.
BIOLOGICAL PSYCHIATRY (2010)
5-HT1A receptor-regulated signal transduction pathways in brain
Abigail M. Polter et al.
CELLULAR SIGNALLING (2010)
Improving intersubject image registration using tissue-class information benefits robustness and accuracy of multi-atlas based anatomical segmentation
Rolf A. Heckemann et al.
NEUROIMAGE (2010)
Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET
Matthew S. Milak et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest
Ioannis S. Gousias et al.
NEUROIMAGE (2008)
Functional selectivity through protean and biased agonism: Who steers the ship?
Terry Kenakin
MOLECULAR PHARMACOLOGY (2007)
Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-C-11]WAY-100635 - considerations on the validity of cerebellum as a reference region
Jussi Hirvonen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Increased serotonin receptor availability in human sleep:: Evidence from an [18F]MPPF PET study in narcolepsy
C Derry et al.
NEUROIMAGE (2006)
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
V Kepe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography
RV Parsey et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Multiple signaling states of G-protein-coupled receptors
DM Perez et al.
PHARMACOLOGICAL REVIEWS (2005)
[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS
MR Turner et al.
BRAIN (2005)
5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy:: an [18F]MPPF-PET study
I Merlet et al.
BRAIN (2004)
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe
A Hammers et al.
HUMAN BRAIN MAPPING (2003)
Tremor in Parkinson's disease and serotonergic dysfunction -: An 11C-WAY 100635 PET study
M Doder et al.
NEUROLOGY (2003)
Large-amplitude 5-HT1A receptor activation:: a new mechanism of profound, central analgesia
FC Colpaert et al.
NEUROPHARMACOLOGY (2002)
Modeling [18F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection
N Costes et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
A database of [C-11]WAY-100635 binding to 5-HT1A receptors in normal male volunteers: Normative data and relationship to methodological, demographic, physiological, and behavioral variables
EA Rabiner et al.
NEUROIMAGE (2002)
Graphical analysis of PET data applied to reversible and irreversible tracers
J Logan
NUCLEAR MEDICINE AND BIOLOGY (2000)
5-HT1A receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems
J Watson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Quantitative imaging of 5-HT1A receptor binding in healthy volunteers with [18F]p-MPPF
J Passchier et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)
Share Paper
